Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 9, 2021
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
[ Tue, Mar 09th 2021
] - WOPRAI
Mon, March 8, 2021
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
[ Mon, Mar 08th 2021
] - WOPRAI
Matthew Harrison Maintained (TSHA) at Buy with Increased Target to $30 on, Mar 8th, 2021
Matthew Harrison of Morgan Stanley, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Buy with Increased Target from $29 to $30 on, Mar 8th, 2021.
Matthew has made no other calls on TSHA in the last 4 months.
There are 3 other peers that have a rating on TSHA. Out of the 3 peers that are also analyzing TSHA, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Matthew
- Gbola Amusa of "Chardan Capital" Maintained at Strong Buy with Increased Target to $60 on, Thursday, March 4th, 2021
- Raju Prasad of "William Blair" Initiated at Buy and Held Target at $46 on, Wednesday, February 24th, 2021
- Kevin DeGeeter of "Oppenheimer" Initiated at Buy on, Tuesday, January 5th, 2021
